Cooperative Agreement NU2RGH001918
- Summary The City of New York Department of Health and Mental Hygiene received a $10.3 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, awarded July 1, 2025, through June 30, 2030. This award supports the Strengthening Vaccine-Preventable Disease Prevention and Response program, which aims to combat declining vaccination coverage and rising cases of vaccine-preventable diseases (VPDs) such as...
- The Rhode Island Department of Health, Office of Immunization received a Cooperative Agreement award of $1,980,349 from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283), effective July 1, 2025, through June 30, 2030. This award supports the Strengthening Vaccine Preventable Disease (VPD) Prevention and Response initiative, which aims to enhance immunization program infrastructure, increase vaccination coverage across...
- Federal Cooperative Agreement Summary The District of Columbia Department of Health received a $3.8 million cooperative agreement from the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective July 1, 2025, through June 30, 2030, supports a comprehensive immunization program enhancement initiative addressing vaccine-preventable disease...
- Federal Cooperative Agreement Award Summary The Chicago Department of Public Health received a $6.42M Cooperative Agreement from the National Center for Immunization and Respiratory Diseases (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268), effective July 1, 2025 through June 30, 2030. This five-year award supports the establishment and maintenance of preventive health service programs to immunize Chicago residents against vaccine-preventable diseases including...
- Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases awarded a Cooperative Agreement totaling $378,547 to the Palau Ministry of Health, effective July 1, 2025 through June 30, 2030, under the CDC Investigations and Technical Assistance program (CFDA 93.283). This award supports the Palau Immunization Program's efforts to strengthen vaccine-preventable disease (VPD) prevention and response...
- Summary: Strengthening Vaccine-Preventable Disease Prevention and Response The Pennsylvania Department of Health received a $6.35 million Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) for the period July 1, 2025 through June 30, 2030. The award supports the Pennsylvania Immunization Program's core immunization services and disease prevention activities delivered through the...
- Federal Cooperative Agreement Award Summary The City of Houston, through its Houston Department of Health and Human Services, received a $4.18M Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, under the Grants to States for Medicaid program (CFDA 93.778). Effective July 1, 2025, through June 30, 2030, this award supports the Strengthening Vaccine-Preventable Disease Prevention and Response initiative....
- Federal Cooperative Agreement Summary Award Overview The Washington State Department of Health, Office of Immunization received a $9,474,623 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases under the Strengthening Vaccine-Preventable Disease Prevention & Response program (CDC-RFA-IP-25-0007). The five-year award, effective July 1, 2025 through June 30, 2030, is structured across three components with...
- Federal Cooperative Agreement Summary The Illinois Department of Public Health received a $3.43 million cooperative agreement from the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, effective July 1, 2025 through June 30, 2030, to strengthen vaccine-preventable disease prevention and response across Illinois. Under this award, IDPH will enhance public health immunization infrastructure and services by implementing activities aligned...
- CNMI CHCC Immunization and Vaccines for Children Program The Commonwealth Healthcare Corporation (CHC) received a cooperative agreement award of $1,090,255 from the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases under the CDC Investigations and Technical Assistance program (CFDA 93.283), effective July 1, 2025, through June 30, 2030. The award supports CHC's immunization program serving the Commonwealth of the Northern Mariana Islands...
CAPACITY BUILDING FOR NATIONAL IMMUNIZATION PROGRAMS IN THE EASTERN MEDITERRANEAN REGION - IMMUNIZATIONS ARE AMONG THE MOST SUCCESSFUL AND COST-EFFECTIVE HEALTH INTERVENTIONS EVER DEVISED. THEY HAVE REDUCED CHILD DEATHS AND DISEASE PREVALENCE RADICALLY. THEY HAVE ENABLED THE ERADICATION OF SMALLPOX, LOWERED THE GLOBAL INCIDENCE OF POLIO BY MORE THAN 99% AND NEONATAL TETANUS BY 94%, AND ACHIEVED DRAMATIC REDUCTIONS IN ILLNESS, DISABILITY, AND DEATH FROM COMMON CHILDHOOD DISEASES .EASTERN MEDITERRANEAN REGION (EMR) IS A VERY DIVERSE AND FRAGILE REGION WITH CONSIDERABLE VARIATIONS IN SIZE, POPULATION, CAPACITIES, AND INCOME. IT INCLUDES COUNTRIES WITH ROBUST AND RESILIENT HEALTH SYSTEMS, CAPABLE OF KEEPING HIGH VACCINATION COVERAGE RATES, AND COUNTRIES WITH MAJOR SOCIO-ECONOMIC, HUMANITARIAN, AND SECURITY ISSUES THAT NEGATIVELY AFFECT THE NATIONAL COVERAGE RATES. THE PROPOSAL IS ALIGNED WITH THE POLIO ENDGAME STRATEGY (2019-2023) AND IMMUNIZATION AGENDA 2030. IT AIMS AT STRENGTHENING IMMUNIZATION PROGRAM CAPACITIES AND INCREASE ITS IMPACT TO REDUCE MORTALITY AND MORBIDITY OF VPDS AND TO SUPPORT COUNTRIES TO ACHIEVE THE POLIO ERADICATION AND MEASLES ELIMINATION GOALS. ALL PROPOSED ACTIVITIES ARE TAILORED ACCORDING TO GHD?S VAST EXPERIENCE IN THE REGION, THE COUNTRIES? LOCAL CONTEXTS GUIDED AND BY RECENTLY PUBLISHED GLOBAL AND REGIONAL GUIDELINES AND RECOMMENDATIONS. THROUGHOUT THE FIVE YEARS, GHD WILL APPLY COMPREHENSIVE STRATEGIES TO CONTRIBUTE TO REDUCING HEALTH DISPARITIES RELATED TO VPDS, WHICH INCLUDE IMPROVE THE CAPACITY OF THE IMMUNIZATION WORKFORCE, SURVEILLANCE AND OUTBREAK RESPONSE, ENHANCED MICROPLANNING TO REACH THE UNDER-VACCINATED POPULATIONS, DEMAND CREATION AND SUPPORT SERVICE DELIVERY IN HIGH-RISK AREAS, AND SUPPORT DATA-DRIVEN IMMUNIZATION ACTIVITIES. THIS PROJECT?S PROPOSAL PRIORITIZES A SET OF ACTIVITIES THAT WILL CONTRIBUTE TO ACHIEVING THE SHORT-TERM OUTCOMES; IMPROVED VACCINATION COVERAGE IN PRIORITY AREAS, POLIO AND OTHER VPD OUTBREAKS STOPPED WITHIN GLOBALLY ESTABLISHED TIME FRAMES, POLIO AND OTHER VPD SURVEILLANC E QUALITY IMPROVED, INCREASED CAPACITY AND FUNCTIONALITY OF NITAGS. ALSO, INCREASE GOVERNMENT OWNERSHIP OF EPI PROGRAMS IN PRIORITY / HIGH- RISK AREAS AS INTERMEDIATE OUTCOME.IN SUBSEQUENT YEARS, GHD WILL FOCUS ON IMPROVING VACCINATION COVERAGE NATIONALLY IN TARGETED COUNTRIES, REDUCING POLIO AND OTHER VPD OUTBREAKS/EMERGENCIES, AND POLIO AND THE VPD SURVEILLANCE QUALITY MAINTAINING AS MEDIUM-TERM OUTCOMES. WHILE IN LONG-TERM OUTCOMES, GHD PLANS TO STRENGTHEN IMMUNIZATION SYSTEMS, INCLUDING STRENGTHENED VPD DATA AND SURVEILLANCE SYSTEMS AND REDUCING VPD ASSOCIATED MORBIDITY AND MORTALITY. GHD WILL WORK TO IMPLEMENT ACTIVITIES BASED ON ITS EXPERIENCE GAINED THROUGH 10 YEARS OF WORKING CLOSELY WITH THE COUNTRIES IN EMR AND THE EXTENSIVE KNOWLEDGE AND UNDERSTANDING OF THE REGION?S CONTEXT AND COMPLEXITIES. INCLUDING THE LAST SIX YEARS OF STRENGTHENING THE PUBLIC HEALTH SYSTEM AND SUPPORTING THE NATIONAL EXPANDED PROGRAM FOR IMMUNIZATIONS IN KEY PRIORITY EMR COUNTRIES. GHD WILL BE PARTNERING WITH THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND COLLABORATE WITH RELEVANT PARTNERS TO ENSURE PROJECT?S EFFICIENCY AND SUSTAINABILITY."1" GLOBAL ROUTINE IMMUNIZATION STRATEGIES AND PRACTICES (GRISP) HTTPS://APPS.WHO.INT/IRIS/REST/BITSTREAMS/908228/RETRIEVE
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 4/3/26 | ||
| Not listed | $0 | 2/21/26 | ||
| Not listed | $0 | 2/21/26 | ||
| Not listed | $0 | 7/24/25 | ||
| Not listed | $25.0k | 7/24/25 |